COVID: Mild cases at risk of deterioration to be given antibody drug
Regeneron was authorized in November for emergency use by the US Food and Drug Administration (FDA).
Full Article
COVID: Mild cases at risk of deterioration to be given antibody drug
Jerusalem Post
0 shares
1 views
You might like
Related news coverage
CDC Advisers Try To Work Out The Details On Booster Shots
Newsy
Watch VideoWith booster doses of Pfizer's COVID-19 vaccine now authorized in the U.S., government advisers reconvened on Thursday..
Advertisement
More coverage
Melbourne Protesters Rally Against Coronavirus Restrictions
Hundreds of people demonstrated Tuesday in Australia’s second-largest city to protest coronavirus restrictions the government..
VOA News